Cargando…

A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility

OBJECTIVES: We aimed to present the state of the art of CT- and MRI-based radiomics in the context of ovarian cancer (OC), with a focus on the methodological quality of these studies and the clinical utility of these proposed radiomics models. METHODS: Original articles investigating radiomics in OC...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Meng-Lin, Ren, Jing, Jin, Zheng-Yu, Liu, Xin-Yu, He, Yong-Lan, Li, Yuan, Xue, Hua-Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317928/
https://www.ncbi.nlm.nih.gov/pubmed/37395888
http://dx.doi.org/10.1186/s13244-023-01464-z
_version_ 1785067927575199744
author Huang, Meng-Lin
Ren, Jing
Jin, Zheng-Yu
Liu, Xin-Yu
He, Yong-Lan
Li, Yuan
Xue, Hua-Dan
author_facet Huang, Meng-Lin
Ren, Jing
Jin, Zheng-Yu
Liu, Xin-Yu
He, Yong-Lan
Li, Yuan
Xue, Hua-Dan
author_sort Huang, Meng-Lin
collection PubMed
description OBJECTIVES: We aimed to present the state of the art of CT- and MRI-based radiomics in the context of ovarian cancer (OC), with a focus on the methodological quality of these studies and the clinical utility of these proposed radiomics models. METHODS: Original articles investigating radiomics in OC published in PubMed, Embase, Web of Science, and the Cochrane Library between January 1, 2002, and January 6, 2023, were extracted. The methodological quality was evaluated using the radiomics quality score (RQS) and Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). Pairwise correlation analyses were performed to compare the methodological quality, baseline information, and performance metrics. Additional meta-analyses of studies exploring differential diagnoses and prognostic prediction in patients with OC were performed separately. RESULTS: Fifty-seven studies encompassing 11,693 patients were included. The mean RQS was 30.7% (range − 4 to 22); less than 25% of studies had a high risk of bias and applicability concerns in each domain of QUADAS-2. A high RQS was significantly associated with a low QUADAS-2 risk and recent publication year. Significantly higher performance metrics were observed in studies examining differential diagnosis; 16 such studies as well as 13 exploring prognostic prediction were included in a separate meta-analysis, which revealed diagnostic odds ratios of 25.76 (95% confidence interval (CI) 13.50–49.13) and 12.55 (95% CI 8.38–18.77), respectively. CONCLUSION: Current evidence suggests that the methodological quality of OC-related radiomics studies is unsatisfactory. Radiomics analysis based on CT and MRI showed promising results in terms of differential diagnosis and prognostic prediction. CRITICAL RELEVANCE STATEMENT: Radiomics analysis has potential clinical utility; however, shortcomings persist in existing studies in terms of reproducibility. We suggest that future radiomics studies should be more standardized to better bridge the gap between concepts and clinical applications. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-023-01464-z.
format Online
Article
Text
id pubmed-10317928
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-103179282023-07-05 A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility Huang, Meng-Lin Ren, Jing Jin, Zheng-Yu Liu, Xin-Yu He, Yong-Lan Li, Yuan Xue, Hua-Dan Insights Imaging Critical Review OBJECTIVES: We aimed to present the state of the art of CT- and MRI-based radiomics in the context of ovarian cancer (OC), with a focus on the methodological quality of these studies and the clinical utility of these proposed radiomics models. METHODS: Original articles investigating radiomics in OC published in PubMed, Embase, Web of Science, and the Cochrane Library between January 1, 2002, and January 6, 2023, were extracted. The methodological quality was evaluated using the radiomics quality score (RQS) and Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). Pairwise correlation analyses were performed to compare the methodological quality, baseline information, and performance metrics. Additional meta-analyses of studies exploring differential diagnoses and prognostic prediction in patients with OC were performed separately. RESULTS: Fifty-seven studies encompassing 11,693 patients were included. The mean RQS was 30.7% (range − 4 to 22); less than 25% of studies had a high risk of bias and applicability concerns in each domain of QUADAS-2. A high RQS was significantly associated with a low QUADAS-2 risk and recent publication year. Significantly higher performance metrics were observed in studies examining differential diagnosis; 16 such studies as well as 13 exploring prognostic prediction were included in a separate meta-analysis, which revealed diagnostic odds ratios of 25.76 (95% confidence interval (CI) 13.50–49.13) and 12.55 (95% CI 8.38–18.77), respectively. CONCLUSION: Current evidence suggests that the methodological quality of OC-related radiomics studies is unsatisfactory. Radiomics analysis based on CT and MRI showed promising results in terms of differential diagnosis and prognostic prediction. CRITICAL RELEVANCE STATEMENT: Radiomics analysis has potential clinical utility; however, shortcomings persist in existing studies in terms of reproducibility. We suggest that future radiomics studies should be more standardized to better bridge the gap between concepts and clinical applications. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-023-01464-z. Springer Vienna 2023-07-03 /pmc/articles/PMC10317928/ /pubmed/37395888 http://dx.doi.org/10.1186/s13244-023-01464-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Critical Review
Huang, Meng-Lin
Ren, Jing
Jin, Zheng-Yu
Liu, Xin-Yu
He, Yong-Lan
Li, Yuan
Xue, Hua-Dan
A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility
title A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility
title_full A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility
title_fullStr A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility
title_full_unstemmed A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility
title_short A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility
title_sort systematic review and meta-analysis of ct and mri radiomics in ovarian cancer: methodological issues and clinical utility
topic Critical Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317928/
https://www.ncbi.nlm.nih.gov/pubmed/37395888
http://dx.doi.org/10.1186/s13244-023-01464-z
work_keys_str_mv AT huangmenglin asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT renjing asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT jinzhengyu asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT liuxinyu asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT heyonglan asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT liyuan asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT xuehuadan asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT huangmenglin systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT renjing systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT jinzhengyu systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT liuxinyu systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT heyonglan systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT liyuan systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT xuehuadan systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility